300 results
Are higher operator volumes for unprotected left main stem percutaneous coronary intervention associated with improved patient outcomes?
15 Jun 2020
The presented results appear to further strengthen the notion that operator’s experience may be an important effect modifier in LM PCI.

Reviewer
Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from the STS/ACC TVT registry
09 Jun 2020
TAVR with self-expandable bioprosthesis appears to be an acceptable therapeutic strategy in patients with bicuspid aortic valve disease.

Reviewer
Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale
14 May 2020
This work aimed at assessing the respective influence of interatrial shunt size and presence of ASA on the risk of recurrent stroke in medically treated patients after an index cryptogenic ischemic stroke in patients with PFO without evidence of alternative causes.

Reviewer
Multi- vs culprit-vessel percutaneous coronary intervention in cardiogenic shock
04 May 2020
This study compares outcomes of patients enrolled in the National Cardiogenic Shock Initiative (NCSI) registry treated using a strategy of MV-PCI vs CV-PCI and examines outcomes in patients treated with early MCS.

Reviewer
The utility of rapid atrial pacing immediately post-TAVR to predict the need for pacemaker implantation
04 May 2020
The investigators proposed rapid atrial pacing (RAP) to further risk-stratify patients for post-TAVR PPI. Atrial pacing can be easily performed during the TAVR procedure since a temporary pacemaker (TPM) is routinely positioned in the right ventricle during valve implantation.

Reviewer
Ten-year outcomes after DES versus CABG for LM coronary disease: extended follow-up of the PRECOMBAT trial
27 Apr 2020
This 10-year follow-up of the randomised PRECOMBAT trial adds to the already published long-term randomised comparisons of PCI vs. CABG for LM disease, including the data from SYNTAX (10 years), EXCEL (5 years) and NOBLE (5 years) trials.

Reviewer
Rivaroxaban in peripheral artery disease after revascularisation
22 Apr 2020
VOYAGER-PAD (presented at the ACC 2020 Scientific Sessions Virtual Event) evaluates whether rivaroxaban plus aspirin is better than aspirin alone in reducing MALE in symptomatic patients undergoing lower limb revascularisation.

Reviewer

Reviewer
ISCHEMIA trial : what's new for stable ischemic heart disease patients ?
09 Apr 2020
The ISCHEMIA trial was designed to evaluate the clinical impact of systematic invasive management in patients with stable ischemic heart disease and significant inducible ischemia. Read this review by guest expert reviewers Francesco Burzotta and Carlo Trani.

Reviewer

Reviewer
Ticagrelor or prasugrel in patients with acute coronary syndromes - ISAR-REACT 5
06 Apr 2020
The objective of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 trial is to test the hypothesis that the ticagrelor strategy is superior to prasugrel strategy in patients with ACS in a composite clinical outcomes.

Reviewer

Reviewer
Transcatheter self-expandable valve implantation for aortic stenosis in small aortic annuli: the TAVI-SMALL registry
30 Mar 2020
This retrospective study represents the first direct comparison among different transcatheter SEVs in patients characterized by small annuli undergoing TAVI.

Reviewer